Abbott Japan and Eisai have Cleared the Condition for Approval of Humira(R), a ... - MarketWatch (press release)

Abbott Japan and Eisai have Cleared the Condition for Approval of Humira(R), a ... MarketWatch (press release) In approbatory plaque psoriasis and disease of the skin arthropica as additional indications for Humira in Jan 2010, the MHLW imposed the following condition: "A post-marketing drug use results survey of all patients receiving Humira must Be conducted until ... and more » Link To Article